IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP)
118.21
-2.96 (-2.44%)
May 22, 2026, 3:30 PM IST
NSE:IOLCP Revenue
In the fiscal year ending March 31, 2026, IOL Chemicals and Pharmaceuticals had annual revenue of 23.40B INR with 12.56% growth. IOL Chemicals and Pharmaceuticals had revenue of 6.21B in the quarter ending March 31, 2026, with 17.72% growth.
Revenue
23.40B
Revenue Growth
+12.56%
P/S Ratio
1.50
Revenue / Employee
8.02M
Employees
2,891
Market Cap
34.87B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 23.40B | 2.61B | 12.56% |
| Mar 31, 2025 | 20.79B | -535.80M | -2.51% |
| Mar 31, 2024 | 21.33B | -843.20M | -3.80% |
| Mar 31, 2023 | 22.17B | 330.90M | 1.52% |
| Mar 31, 2022 | 21.84B | 2.17B | 11.03% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Akums Drugs and Pharmaceuticals | 43.59B |
| Sun Pharma Advanced Research Company | 18.90B |
| Indoco Remedies | 18.45B |
| Aarti Pharmalabs | 18.01B |
| Innova Captab | 16.30B |
| Solara Active Pharma Sciences | 13.75B |
| Windlas Biotech | 9.22B |
| Orchid Pharma | 8.11B |
IOL Chemicals and Pharmaceuticals News
- 2 months ago - IOL Chemicals and Pharmaceuticals reports promoter group acquisition of ₹40,00,210 in shares - Business Upturn
- 3 months ago - IOL Chemicals And Pharmaceuticals Ltd (BOM:524164) Q3 2026 Earnings Call Highlights: Strong ... - GuruFocus
- 3 months ago - Q3 2026 IOL Chemicals and Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus
- 6 months ago - IOL Chemicals receives EDQM Certificate of Suitability for Minoxidil API - Business Upturn
- 6 months ago - Q2 2026 IOL Chemicals and Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus
- 10 months ago - IOL Chemicals shares surge nearly 3.5% after Q1 profit rises 13% YoY - Business Upturn
- 10 months ago - IOL Chemicals Q1 results: Net profit rises 13% YoY to Rs 34 crore; EBITDA margin improves to 11.4% - Business Upturn
- 1 year ago - IOL Chemicals and Pharmaceuticals shares jump nearly 5% after China approves Ibuprofen export - Business Upturn